[{"edinetCode":"E05385","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1506.0,"averageTemporaryStaff":173.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":24075000.0,"sharesOwendPercent":0.5782,"outstandingShares":null,"numberOfSubsidiary":22.0,"bps":538.88,"equityRatio":0.399,"cashAndCashEquivalents":7423786000.0,"assets":56253034000.0,"currentAssets":18145949000.0,"fixedAsset":38107085000.0,"tangibleFixedAssets":17104576000.0,"intangibleFixedAssets":371133000.0,"investmentAndOtherAssets":20631375000.0,"liabilities":33779610000.0,"currentLiabilities":19675898000.0,"shorTermDept":11557671000.0,"currentPortionOfBonds":50000000.0,"currentPortionOfLongTermDebt":null,"fixedLiabilities":14103711000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":10806133000.0,"netAsset":22473424000.0,"capitalStock":11780999000.0,"capital":9679070000.0,"capitalSurplus":10362434000.0,"accumulatedEarnings":-8260335000.0,"treasuryStock":-170000.0,"valuationAndConversionAdjustments":10653709000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":17244496000.0,"costOfSales":12884249000.0,"grossProfit":4360247000.0,"sgaExpenses":6152753000.0,"salaryAndBenefit":1999539000.0,"depreciationAndSGA":251330000.0,"RDExpenses":600603000.0,"operatingIncome":-1792506000.0,"nonOperatingIncome":341050000.0,"nonOperatingExpenses":654068000.0,"interestExpense":378116000.0,"ordinaryProfit":-2105524000.0,"extraordinaryGain":1452478000.0,"extraordinaryLoss":111646000.0,"incomeBeforeTax":-764692000.0,"incomeTaxes":127781000.0,"netIncome":-892473000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-915938000.0,"comprehensiveIncome":4808849000.0,"eps":-22.18,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-849807000.0,"depreciationAndCashflowFromOperatingActivities":1545798000.0,"cashFlowFromInvestingActivities":-314206000.0,"cashFlowFromFinancialActivities":3815122000.0,"changesInCashAndCashEquivalents":2498166000.0,"列1":"asr","submitDate":"2017\/6\/30","stockCode":2395,"accountingYear":"第44期(自　平成28年４月１日　至　平成29年３月31日)","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1385.0,"averageTemporaryStaff":167.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":23806000.0,"sharesOwendPercent":0.5718,"outstandingShares":null,"numberOfSubsidiary":20.0,"bps":628.33,"equityRatio":0.454,"cashAndCashEquivalents":5294076000.0,"assets":57608379000.0,"currentAssets":15290094000.0,"fixedAsset":42318284000.0,"tangibleFixedAssets":14654241000.0,"intangibleFixedAssets":288763000.0,"investmentAndOtherAssets":27375279000.0,"liabilities":31392722000.0,"currentLiabilities":20002896000.0,"shorTermDept":11523878000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":11389825000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6924257000.0,"netAsset":26215656000.0,"capitalStock":7982364000.0,"capital":9679070000.0,"capitalSurplus":10362434000.0,"accumulatedEarnings":-12058970000.0,"treasuryStock":-170000.0,"valuationAndConversionAdjustments":18176314000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":16600550000.0,"costOfSales":11396418000.0,"grossProfit":5204132000.0,"sgaExpenses":5901604000.0,"salaryAndBenefit":1882066000.0,"depreciationAndSGA":244530000.0,"RDExpenses":518395000.0,"operatingIncome":-697471000.0,"nonOperatingIncome":852426000.0,"nonOperatingExpenses":968036000.0,"interestExpense":374004000.0,"ordinaryProfit":-813081000.0,"extraordinaryGain":480491000.0,"extraordinaryLoss":1175403000.0,"incomeBeforeTax":-1507993000.0,"incomeTaxes":2013233000.0,"netIncome":-3521227000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-3555948000.0,"comprehensiveIncome":4001789000.0,"eps":-85.41,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1344254000.0,"depreciationAndCashflowFromOperatingActivities":1472814000.0,"cashFlowFromInvestingActivities":837824000.0,"cashFlowFromFinancialActivities":-4224327000.0,"changesInCashAndCashEquivalents":-2129710000.0,"列1":"asr","submitDate":"2018\/6\/28","stockCode":2395,"accountingYear":"第45期(自　平成29年４月１日　至　平成30年３月31日)","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":935.0,"averageTemporaryStaff":179.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":26921000.0,"sharesOwendPercent":0.6467,"outstandingShares":null,"numberOfSubsidiary":20.0,"bps":682.38,"equityRatio":0.523,"cashAndCashEquivalents":5134734000.0,"assets":54329021000.0,"currentAssets":11666428000.0,"fixedAsset":42662593000.0,"tangibleFixedAssets":13686650000.0,"intangibleFixedAssets":92529000.0,"investmentAndOtherAssets":28883413000.0,"liabilities":25851202000.0,"currentLiabilities":17767584000.0,"shorTermDept":11348192000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":8083617000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":3894755000.0,"netAsset":28477819000.0,"capitalStock":9958718000.0,"capital":9679070000.0,"capitalSurplus":10362434000.0,"accumulatedEarnings":-10082616000.0,"treasuryStock":-170000.0,"valuationAndConversionAdjustments":18450274000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":15658678000.0,"costOfSales":9480910000.0,"grossProfit":6177767000.0,"sgaExpenses":5347972000.0,"salaryAndBenefit":1803008000.0,"depreciationAndSGA":213442000.0,"RDExpenses":339818000.0,"operatingIncome":829795000.0,"nonOperatingIncome":1400065000.0,"nonOperatingExpenses":616207000.0,"interestExpense":377796000.0,"ordinaryProfit":1613653000.0,"extraordinaryGain":750242000.0,"extraordinaryLoss":713194000.0,"incomeBeforeTax":1650701000.0,"incomeTaxes":-308088000.0,"netIncome":1958789000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1950307000.0,"comprehensiveIncome":2232990000.0,"eps":46.84,"dilutedEps":null,"dividendPerShare":null,"per":19.2,"roe":0.071,"cashFlowFromOperatingActivities":2892655000.0,"depreciationAndCashflowFromOperatingActivities":1361610000.0,"cashFlowFromInvestingActivities":434763000.0,"cashFlowFromFinancialActivities":-3501621000.0,"changesInCashAndCashEquivalents":-159341000.0,"列1":"asr","submitDate":"2019\/7\/1","stockCode":2395,"accountingYear":"第46期(自　2018年４月１日　至　2019年３月31日)","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.506,"cashAndCashEquivalents":null,"assets":47432646000.0,"currentAssets":10635499000.0,"fixedAsset":36797146000.0,"tangibleFixedAssets":13574355000.0,"intangibleFixedAssets":178403000.0,"investmentAndOtherAssets":23044387000.0,"liabilities":23334152000.0,"currentLiabilities":17274493000.0,"shorTermDept":11393194000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":6059658000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":3318469000.0,"netAsset":24098493000.0,"capitalStock":9792484000.0,"capital":9679070000.0,"capitalSurplus":5194304000.0,"accumulatedEarnings":-5080719000.0,"treasuryStock":-170000.0,"valuationAndConversionAdjustments":14231437000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2730374000.0,"costOfSales":1245637000.0,"grossProfit":1484737000.0,"sgaExpenses":1211273000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":273463000.0,"nonOperatingIncome":158253000.0,"nonOperatingExpenses":382498000.0,"interestExpense":50788000.0,"ordinaryProfit":49218000.0,"extraordinaryGain":178000.0,"extraordinaryLoss":4405000.0,"incomeBeforeTax":44991000.0,"incomeTaxes":83360000.0,"netIncome":-38369000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-41336000.0,"comprehensiveIncome":-4257199000.0,"eps":-0.99,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":2395,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":25156000.0,"sharesOwendPercent":0.6043,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.474,"cashAndCashEquivalents":4619587000.0,"assets":44268974000.0,"currentAssets":11442124000.0,"fixedAsset":32826850000.0,"tangibleFixedAssets":13547588000.0,"intangibleFixedAssets":209512000.0,"investmentAndOtherAssets":19069749000.0,"liabilities":23139198000.0,"currentLiabilities":12099417000.0,"shorTermDept":5754681000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":11039781000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":8408247000.0,"netAsset":21129775000.0,"capitalStock":10713573000.0,"capital":9679070000.0,"capitalSurplus":5196804000.0,"accumulatedEarnings":-4162131000.0,"treasuryStock":-170000.0,"valuationAndConversionAdjustments":10271134000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":6389274000.0,"costOfSales":2894916000.0,"grossProfit":3494358000.0,"sgaExpenses":2415775000.0,"salaryAndBenefit":705959000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1078583000.0,"nonOperatingIncome":636810000.0,"nonOperatingExpenses":456718000.0,"interestExpense":123857000.0,"ordinaryProfit":1258675000.0,"extraordinaryGain":794000.0,"extraordinaryLoss":6693000.0,"incomeBeforeTax":1252776000.0,"incomeTaxes":299975000.0,"netIncome":952801000.0,"netIncomeAttributableToOwnersOfTheParentCompany":877251000.0,"comprehensiveIncome":-7225917000.0,"eps":21.07,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1331218000.0,"depreciationAndCashflowFromOperatingActivities":563617000.0,"cashFlowFromInvestingActivities":-510289000.0,"cashFlowFromFinancialActivities":-1313488000.0,"changesInCashAndCashEquivalents":-515147000.0,"列1":"q2r","submitDate":"2019\/11\/8","stockCode":2395,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.442,"cashAndCashEquivalents":null,"assets":39292474000.0,"currentAssets":10971690000.0,"fixedAsset":28320784000.0,"tangibleFixedAssets":13736983000.0,"intangibleFixedAssets":198808000.0,"investmentAndOtherAssets":14384992000.0,"liabilities":21825093000.0,"currentLiabilities":12532363000.0,"shorTermDept":6176549000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":9292729000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":7909647000.0,"netAsset":17467381000.0,"capitalStock":11441763000.0,"capital":9679070000.0,"capitalSurplus":5196804000.0,"accumulatedEarnings":-3433941000.0,"treasuryStock":-170000.0,"valuationAndConversionAdjustments":5936374000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":10071077000.0,"costOfSales":4828659000.0,"grossProfit":5242417000.0,"sgaExpenses":3665403000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1577013000.0,"nonOperatingIncome":925082000.0,"nonOperatingExpenses":359748000.0,"interestExpense":179928000.0,"ordinaryProfit":2142348000.0,"extraordinaryGain":955000.0,"extraordinaryLoss":33629000.0,"incomeBeforeTax":2109673000.0,"incomeTaxes":411230000.0,"netIncome":1698442000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1605441000.0,"comprehensiveIncome":-10815054000.0,"eps":38.56,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/10","stockCode":2395,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":985.0,"averageTemporaryStaff":177.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":23359000.0,"sharesOwendPercent":0.5611,"outstandingShares":null,"numberOfSubsidiary":20.0,"bps":391.23,"equityRatio":0.418,"cashAndCashEquivalents":5243258000.0,"assets":39002293000.0,"currentAssets":12409899000.0,"fixedAsset":26592394000.0,"tangibleFixedAssets":13699735000.0,"intangibleFixedAssets":194361000.0,"investmentAndOtherAssets":12698297000.0,"liabilities":22620445000.0,"currentLiabilities":12951162000.0,"shorTermDept":5998285000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":9669283000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":8217304000.0,"netAsset":16381848000.0,"capitalStock":12386673000.0,"capital":9679070000.0,"capitalSurplus":5196804000.0,"accumulatedEarnings":-2489003000.0,"treasuryStock":-197000.0,"valuationAndConversionAdjustments":3901398000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":14561084000.0,"costOfSales":6945351000.0,"grossProfit":7615732000.0,"sgaExpenses":5387480000.0,"salaryAndBenefit":1541564000.0,"depreciationAndSGA":147958000.0,"RDExpenses":400853000.0,"operatingIncome":2228251000.0,"nonOperatingIncome":1382600000.0,"nonOperatingExpenses":489547000.0,"interestExpense":235012000.0,"ordinaryProfit":3121305000.0,"extraordinaryGain":1102000.0,"extraordinaryLoss":59740000.0,"incomeBeforeTax":3062667000.0,"incomeTaxes":414541000.0,"netIncome":2648126000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2550379000.0,"comprehensiveIncome":-11900559000.0,"eps":61.25,"dilutedEps":null,"dividendPerShare":null,"per":8.6,"roe":0.114,"cashFlowFromOperatingActivities":3018289000.0,"depreciationAndCashflowFromOperatingActivities":1229150000.0,"cashFlowFromInvestingActivities":-1455135000.0,"cashFlowFromFinancialActivities":-1449556000.0,"changesInCashAndCashEquivalents":108523000.0,"列1":"asr","submitDate":"2020\/6\/26","stockCode":2395,"accountingYear":"第47期(自　2019年４月１日　至　2020年３月31日)","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.436,"cashAndCashEquivalents":null,"assets":41611399000.0,"currentAssets":13382063000.0,"fixedAsset":28229335000.0,"tangibleFixedAssets":13592071000.0,"intangibleFixedAssets":194740000.0,"investmentAndOtherAssets":14442524000.0,"liabilities":23393009000.0,"currentLiabilities":10405523000.0,"shorTermDept":4530967000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":12987486000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":11110118000.0,"netAsset":18218390000.0,"capitalStock":12821873000.0,"capital":9679070000.0,"capitalSurplus":2307021000.0,"accumulatedEarnings":835979000.0,"treasuryStock":-197000.0,"valuationAndConversionAdjustments":5307469000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":3173472000.0,"costOfSales":1589886000.0,"grossProfit":1583585000.0,"sgaExpenses":1135876000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":447708000.0,"nonOperatingIncome":414309000.0,"nonOperatingExpenses":129556000.0,"interestExpense":51726000.0,"ordinaryProfit":732461000.0,"extraordinaryGain":1078000.0,"extraordinaryLoss":2177000.0,"incomeBeforeTax":731362000.0,"incomeTaxes":86481000.0,"netIncome":644881000.0,"netIncomeAttributableToOwnersOfTheParentCompany":643360000.0,"comprehensiveIncome":2051050000.0,"eps":15.45,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/7","stockCode":2395,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":23380000.0,"sharesOwendPercent":0.5616,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.412,"cashAndCashEquivalents":5476225000.0,"assets":35365446000.0,"currentAssets":12508090000.0,"fixedAsset":22857356000.0,"tangibleFixedAssets":13421550000.0,"intangibleFixedAssets":182880000.0,"investmentAndOtherAssets":9252925000.0,"liabilities":20706048000.0,"currentLiabilities":10154797000.0,"shorTermDept":4134154000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10551250000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":9919738000.0,"netAsset":14659398000.0,"capitalStock":13317806000.0,"capital":9679070000.0,"capitalSurplus":2307021000.0,"accumulatedEarnings":1331912000.0,"treasuryStock":-197000.0,"valuationAndConversionAdjustments":1249824000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":7003509000.0,"costOfSales":3575072000.0,"grossProfit":3428436000.0,"sgaExpenses":2267005000.0,"salaryAndBenefit":733371000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1161431000.0,"nonOperatingIncome":514294000.0,"nonOperatingExpenses":370477000.0,"interestExpense":101130000.0,"ordinaryProfit":1305248000.0,"extraordinaryGain":1225000.0,"extraordinaryLoss":6095000.0,"incomeBeforeTax":1300377000.0,"incomeTaxes":157162000.0,"netIncome":1143215000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1139293000.0,"comprehensiveIncome":-1507941000.0,"eps":27.36,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1019283000.0,"depreciationAndCashflowFromOperatingActivities":574793000.0,"cashFlowFromInvestingActivities":-332757000.0,"cashFlowFromFinancialActivities":-477735000.0,"changesInCashAndCashEquivalents":232966000.0,"列1":"q2r","submitDate":"2020\/11\/6","stockCode":2395,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.411,"cashAndCashEquivalents":null,"assets":35803632000.0,"currentAssets":13676817000.0,"fixedAsset":22126814000.0,"tangibleFixedAssets":13305601000.0,"intangibleFixedAssets":179787000.0,"investmentAndOtherAssets":8641425000.0,"liabilities":21005906000.0,"currentLiabilities":10783845000.0,"shorTermDept":3843406000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10222060000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":9633086000.0,"netAsset":14797726000.0,"capitalStock":13655239000.0,"capital":9679070000.0,"capitalSurplus":2307021000.0,"accumulatedEarnings":1669345000.0,"treasuryStock":-197000.0,"valuationAndConversionAdjustments":1044503000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":10420521000.0,"costOfSales":5394774000.0,"grossProfit":5025746000.0,"sgaExpenses":3399697000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1626049000.0,"nonOperatingIncome":669945000.0,"nonOperatingExpenses":649439000.0,"interestExpense":144265000.0,"ordinaryProfit":1646555000.0,"extraordinaryGain":50011000.0,"extraordinaryLoss":10470000.0,"incomeBeforeTax":1686096000.0,"incomeTaxes":199493000.0,"netIncome":1486602000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1476725000.0,"comprehensiveIncome":-1369613000.0,"eps":35.47,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/5","stockCode":2395,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":986.0,"averageTemporaryStaff":207.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":24233000.0,"sharesOwendPercent":0.5821,"outstandingShares":null,"numberOfSubsidiary":22.0,"bps":377.94,"equityRatio":0.426,"cashAndCashEquivalents":7279835000.0,"assets":36972404000.0,"currentAssets":14780029000.0,"fixedAsset":22192374000.0,"tangibleFixedAssets":12897971000.0,"intangibleFixedAssets":213762000.0,"investmentAndOtherAssets":9080641000.0,"liabilities":21133617000.0,"currentLiabilities":11915803000.0,"shorTermDept":3486826000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":9217814000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":8669916000.0,"netAsset":15838786000.0,"capitalStock":15840118000.0,"capital":9679070000.0,"capitalSurplus":2306771000.0,"accumulatedEarnings":3854474000.0,"treasuryStock":-197000.0,"valuationAndConversionAdjustments":-105667000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":15110548000.0,"costOfSales":7556144000.0,"grossProfit":7554403000.0,"sgaExpenses":5024869000.0,"salaryAndBenefit":1535857000.0,"depreciationAndSGA":150268000.0,"RDExpenses":392238000.0,"operatingIncome":2529534000.0,"nonOperatingIncome":1303939000.0,"nonOperatingExpenses":188133000.0,"interestExpense":184860000.0,"ordinaryProfit":3645340000.0,"extraordinaryGain":1292502000.0,"extraordinaryLoss":762279000.0,"incomeBeforeTax":4175563000.0,"incomeTaxes":497792000.0,"netIncome":3677771000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3661855000.0,"comprehensiveIncome":-328303000.0,"eps":87.95,"dilutedEps":null,"dividendPerShare":null,"per":7.9,"roe":0.229,"cashFlowFromOperatingActivities":4746687000.0,"depreciationAndCashflowFromOperatingActivities":1187684000.0,"cashFlowFromInvestingActivities":-268657000.0,"cashFlowFromFinancialActivities":-2471074000.0,"changesInCashAndCashEquivalents":2036577000.0,"列1":"asr","submitDate":"2021\/6\/30","stockCode":2395,"accountingYear":"第48期(自　2020年４月１日　至　2021年３月31日)","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.475,"cashAndCashEquivalents":null,"assets":37329133000.0,"currentAssets":13399560000.0,"fixedAsset":23929572000.0,"tangibleFixedAssets":12411086000.0,"intangibleFixedAssets":214868000.0,"investmentAndOtherAssets":11303617000.0,"liabilities":19502308000.0,"currentLiabilities":10814194000.0,"shorTermDept":3218186000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":8688114000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":8179886000.0,"netAsset":17826825000.0,"capitalStock":16880884000.0,"capital":9679070000.0,"capitalSurplus":2306771000.0,"accumulatedEarnings":4895240000.0,"treasuryStock":-197000.0,"valuationAndConversionAdjustments":840434000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":3041254000.0,"costOfSales":1478463000.0,"grossProfit":1562790000.0,"sgaExpenses":1070965000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":491825000.0,"nonOperatingIncome":225036000.0,"nonOperatingExpenses":44051000.0,"interestExpense":35419000.0,"ordinaryProfit":672810000.0,"extraordinaryGain":1360886000.0,"extraordinaryLoss":6407000.0,"incomeBeforeTax":2027289000.0,"incomeTaxes":198575000.0,"netIncome":1828713000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1826541000.0,"comprehensiveIncome":2773813000.0,"eps":43.87,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/4","stockCode":2395,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":26819000.0,"sharesOwendPercent":0.6442,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.488,"cashAndCashEquivalents":6402809000.0,"assets":36785021000.0,"currentAssets":13985078000.0,"fixedAsset":22799943000.0,"tangibleFixedAssets":12670767000.0,"intangibleFixedAssets":215247000.0,"investmentAndOtherAssets":9913928000.0,"liabilities":18725785000.0,"currentLiabilities":11030312000.0,"shorTermDept":2953954000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":7695472000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":7224366000.0,"netAsset":18059236000.0,"capitalStock":18558066000.0,"capital":9679070000.0,"capitalSurplus":2306771000.0,"accumulatedEarnings":6572424000.0,"treasuryStock":-200000.0,"valuationAndConversionAdjustments":-615816000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":7961465000.0,"costOfSales":3641032000.0,"grossProfit":4320433000.0,"sgaExpenses":2351029000.0,"salaryAndBenefit":728907000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1969403000.0,"nonOperatingIncome":630512000.0,"nonOperatingExpenses":70425000.0,"interestExpense":68967000.0,"ordinaryProfit":2529491000.0,"extraordinaryGain":1418842000.0,"extraordinaryLoss":42421000.0,"incomeBeforeTax":3905912000.0,"incomeTaxes":402459000.0,"netIncome":3503453000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3503725000.0,"comprehensiveIncome":2992315000.0,"eps":84.15,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1574015000.0,"depreciationAndCashflowFromOperatingActivities":560946000.0,"cashFlowFromInvestingActivities":380652000.0,"cashFlowFromFinancialActivities":-2921313000.0,"changesInCashAndCashEquivalents":-877026000.0,"列1":"q2r","submitDate":"2021\/11\/2","stockCode":2395,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0},{"edinetCode":"E05385","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.497,"cashAndCashEquivalents":null,"assets":37366806000.0,"currentAssets":15394660000.0,"fixedAsset":21972146000.0,"tangibleFixedAssets":12989278000.0,"intangibleFixedAssets":210528000.0,"investmentAndOtherAssets":8772338000.0,"liabilities":18659141000.0,"currentLiabilities":11429617000.0,"shorTermDept":2968219000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":7229523000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6790431000.0,"netAsset":18707665000.0,"capitalStock":20302308000.0,"capital":9679070000.0,"capitalSurplus":2306771000.0,"accumulatedEarnings":8316667000.0,"treasuryStock":-200000.0,"valuationAndConversionAdjustments":-1726132000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":12946186000.0,"costOfSales":5924777000.0,"grossProfit":7021408000.0,"sgaExpenses":3720904000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":3300504000.0,"nonOperatingIncome":1483464000.0,"nonOperatingExpenses":99868000.0,"interestExpense":98411000.0,"ordinaryProfit":4684099000.0,"extraordinaryGain":1419800000.0,"extraordinaryLoss":59059000.0,"incomeBeforeTax":6044840000.0,"incomeTaxes":789448000.0,"netIncome":5255391000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5247968000.0,"comprehensiveIncome":3633748000.0,"eps":126.05,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/2","stockCode":2395,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05385","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5391,"settlementDate":"2022\/3\/31","submitterName":"株式会社新日本科学","submitterNameEnglish":"SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.","submitterNameKana":"カブシキガイシャシンニホンカガク","location":"鹿児島市宮之浦町２４３８番地","industory":"サービス業","corporateNumber":9340000000000.0}]